Related Experiment Video
Updated: Jul 25, 2025
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Ion Channels and Personalized Medicine in Gynecological Cancers
Ana Ramírez1, Ingrid Ogonaga-Borja2,3, Brenda Acosta2,3
1Facultad de Ciencias Químicas e Ingeniería, Universidad Autónoma de Baja California, Calzada Universidad 14418, Parque Industrial Internacional, Tijuana 22390, Mexico.
Abstract:
Targeted therapy against cancer plays a key role in delivering safer and more efficient treatments. In the last decades, ion channels have been studied for their participation in oncogenic processes because their aberrant expression and/or function have been associated with different types of malignancies, including ovarian, cervical, and endometrial cancer. The altered expression or function of several ion channels have been associated with tumor aggressiveness, increased proliferation, migration, invasion, and metastasis of cancer cells and with poor prognosis in gynecological cancer patients. Most ion channels are integral membrane proteins easily accessible by drugs. Interestingly, a plethora of ion channel blockers have demonstrated anticancer activity. Consequently, some ion channels have been proposed as oncogenes, cancer, and prognostic biomarkers, as well as therapeutic targets in gynecological cancers. Here, we review the association of ion channels with the properties of cancer cells in these tumors, which makes them very promising candidates to be exploited in personalized medicine. The detailed analysis of the expression pattern and function of ion channels could help to improve the clinical outcomes in gynecological cancer patients.
Insights
Ion channels are implicated in gynecological cancers, affecting tumor aggressiveness and patient prognosis. Targeting these channels offers a promising strategy for developing novel, personalized cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Aberrant ion channel expression and function are linked to various gynecological malignancies, including ovarian, cervical, and endometrial cancers.
- Altered ion channel activity correlates with increased tumor aggressiveness, proliferation, migration, invasion, metastasis, and poor prognosis in gynecological cancer patients.
Purpose of the Study:
- To review the association between ion channels and cancer cell properties in gynecological tumors.
- To highlight ion channels as potential therapeutic targets and biomarkers for personalized medicine in gynecological oncology.
Main Methods:
- Literature review of studies investigating ion channel expression and function in gynecological cancers.
- Analysis of the link between ion channel activity and cancer cell hallmarks such as proliferation, migration, and invasion.
Main Results:
- Ion channels are frequently dysregulated in gynecological cancers, contributing to malignant phenotypes.
- Numerous ion channel blockers exhibit anticancer activity, suggesting their therapeutic potential.
- Specific ion channels are proposed as oncogenes, cancer biomarkers, and prognostic indicators.
Conclusions:
- Ion channels are crucial players in gynecological cancer progression and represent promising targets for novel therapeutic strategies.
- Understanding ion channel expression and function can lead to improved clinical outcomes and personalized treatment approaches for gynecological cancer patients.
More Related Videos
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:56Treatment Resistant Cancers
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:38Mitogens and the Cell Cycle
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...